The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Infectious Complications of Chronic Lymphocytic Leukemia
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
McLaughlin, P., Grillo-López, A. J., Link, B. K., Levy, R., Czuczman, M. S., Williams, M. E., Heyman, M. R., Bence-Bruckler, I., White, C. A., Cabanillas, F., et al. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.8.2825 · Cited by 2,755
Fludarabine Compared with Chlorambucil as Primary Therapy for Chronic Lymphocytic Leukemia
Rai, K. R., Peterson, B. L., Appelbaum, F. R., Kolitz, J., Elias, L., Shepherd, L., Hines, J., Threatte, G. A., Larson, R. A., Cheson, B. D., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200012143432402 · Cited by 1,001
Keating, M. J., O’Brien, S., Albitar, M., Lerner, S., Plunkett, W., Giles, F., Andreeff, M., Cortes, J., Faderl, S., Thomas, D., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.12.051 · Cited by 950
Keating, M. J., Flinn, I., Jain, V., Binet, J.-L., Hillmen, P., Byrd, J., Albitar, M., Brettman, L., Santabarbara, P., Wacker, B., et al. (2002) · Blood · doi:10.1182/blood.v99.10.3554 · Cited by 948
Rituximab Dose-Escalation Trial in Chronic Lymphocytic Leukemia
O’Brien, S. M., Kantarjian, H., Thomas, D. A., Giles, F. J., Freireich, E. J., Cortes, J., Lerner, S., & Keating, M. J. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.8.2165 · Cited by 586
Byrd, J. C. (2003) · Blood · doi:10.1182/blood-2002-04-1258 · Cited by 571
Wierda, W., O’Brien, S., Wen, S., Faderl, S., Garcia-Manero, G., Thomas, D., Do, K.-A., Cortes, J., Koller, C., Beran, M., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.12.516 · Cited by 524
Osterborg, A., Dyer, M. J., Bunjes, D., Pangalis, G. A., Bastion, Y., Catovsky, D., & Mellstedt, H. (1997) · Journal of Clinical Oncology · doi:10.1200/jco.1997.15.4.1567 · Cited by 512
Byrd, J. C., Murphy, T., Howard, R. S., Lucas, M. S., Goodrich, A., Park, K., Pearson, M., Waselenko, J. K., Ling, G., Grever, M. R., et al. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.8.2153 · Cited by 508
Lundin, J., Kimby, E., Björkholm, M., Broliden, P.-A., Celsing, F., Hjalmar, V., Möllgård, L., Rebello, P., Hale, G., Waldmann, H., et al. (2002) · Blood · doi:10.1182/blood-2002-01-0159 · Cited by 497
Byrd, J. C. (2005) · Blood · doi:10.1182/blood-2004-03-0796 · Cited by 404
Lozanski, G., Heerema, N. A., Flinn, I. W., Smith, L., Harbison, J., Webb, J., Moran, M., Lucas, M., Lin, T., Hackbarth, M. L., et al. (2004) · Blood · doi:10.1182/blood-2003-10-3729 · Cited by 398
Leporrier, M., Chevret, S., Cazin, B., Boudjerra, N., Feugier, P., Desablens, B., Rapp, M., Jaubert, J., Autrand, C., Diviné, M., et al. (2001) · Blood · doi:10.1182/blood.v98.8.2319 · Cited by 391
Intravenous Immunoglobulin for the Prevention of Infection in Chronic Lymphocytic Leukemia
A Randomized, C. C. T. C. G. F. T. S. O. I. I. C. L. L. (1988) · New England Journal of Medicine · doi:10.1056/nejm198810063191403 · Cited by 367
Rai, K. R., Freter, C. E., Mercier, R. J., Cooper, M. R., Mitchell, B. S., Stadtmauer, E. A., Santábarbara, P., Wacker, B., & Brettman, L. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.06.119 · Cited by 307
Infections in Patients with Chronic Lymphocytic Leukemia Treated with Fludarabine
Anaissie, E. J., Kontoyiannis, D. P., O'Brien, S., Kantarjian, H., Robertson, L., Lerner, S., & Keating, M. J. (1998) · Annals of Internal Medicine · doi:10.7326/0003-4819-129-7-199810010-00010 · Cited by 297
Fludarabine-induced immunosuppression is associated with inhibition of STAT1 signaling
Frank, D. A., Mahajan, S., & Ritz, J. (1999) · Nature Medicine · doi:10.1038/7445 · Cited by 287
Infectious and immunosuppressive complications of purine analog therapy.
Cheson, B. D. (1995) · Journal of Clinical Oncology · doi:10.1200/jco.1995.13.9.2431 · Cited by 260
Faderl, S., Thomas, D. A., O'Brien, S., Garcia-Manero, G., Kantarjian, H. M., Giles, F. J., Koller, C., Ferrajoli, A., Verstovsek, S., Pro, B., et al. (2003) · Blood · doi:10.1182/blood-2002-07-1952 · Cited by 251
Robak, T., Błoński, J. Z., Kasznicki, M., Błasińska-Morawiec, M., Krykowski, E., Dmoszyńska, A., Mrugala-Śpiewak, H., Skotnicki, A. B., Nowak, W., Konopka, L., et al. (2000) · PubMed · doi:10.1182/blood.v96.8.2723.h8002723_2723_2729 · Cited by 218
Effect of Campath-1H antibody on human hematopoietic progenitors in vitro
Gilleece, M., & Dexter, T. (1993) · Blood · doi:10.1182/blood.v82.3.807.807 · Cited by 217
Seymour, J., Kurzrock, R., Freireich, E., & Estey, E. (1994) · Blood · doi:10.1182/blood.v83.10.2906.2906 · Cited by 207
Cost Effectiveness of Prophylactic Intravenous Immune Globulin in Chronic Lymphocytic Leukemia
Weeks, J. C., Tierney, M. R., & Weinstein, M. C. (1991) · New England Journal of Medicine · doi:10.1056/nejm199107113250202 · Cited by 204
Platsoucas, C. D., Galinski, M. R., Kempin, S. J., Reich, L., Clarkson, B., & Good, R. A. (1982) · The Journal of Immunology · doi:10.4049/jimmunol.129.5.2305 · Cited by 151
Tallman, M., & Hakimian, D. (1995) · Blood · doi:10.1182/blood.v86.7.2463.2463 · Cited by 149
Perkins, J. G., Flynn, J. M., Howard, R., et al. (2002) · PubMed · Cited by 144
Serum immunoglobulins in B-chronic lymphocytic leukemia.Natural history and prognostic significance
Rozmán, C., Montserrat, E., & Viñolas, N. (1988) · Cancer · doi:10.1002/1097-0142(19880115)61:2<279::aid-cncr2820610215>3.0.co;2-4 · Cited by 142
Infections in Chronic Lymphocytic Leukemia: Risk Factors, and Impact on Survival, and Treatment
Molica, S. (1994) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428199409056283 · Cited by 132
Crossover study of immunoglobulin replacement therapy in patients with low-grade B-cell tumors
Griffiths, H. R., Brennan, V., Lea, J., Bunch, C., Lee, M. J., & Chapel, H. M. (1989) · Blood · doi:10.1182/blood.v73.2.366.366 · Cited by 124
Lundin, J., Porwit-MacDonald, A., Rossmann, E. D., Karlsson, C., Edman, P., Rezvany, M. R., Kimby, E., Österborg, A., & Mellstedt, H. (2004) · Leukemia · doi:10.1038/sj.leu.2403258 · Cited by 118
Hertenstein, B., Wagner, B., Bunjes, D. W., Duncker, C., Raghavachar, A., Arnold, R., Heimpel, H., & Schrezenmeier, H. (1995) · Blood · doi:10.1182/blood.v86.4.1487.bloodjournal8641487 · Cited by 104
Sinisalo, M., Aittoniemi, J., Oivanen, P., Käyhty, H. M., Ölander, R., & Vilpo, J. (2001) · British Journal of Haematology · doi:10.1046/j.1365-2141.2001.02882.x · Cited by 94
Single-agent/combination therapy of human immunodeficiency virus-related wasting.
Wanke, C. A. (1998) · PubMed · Cited by 77
Rawstron, A. C., Rollinson, Richards, S. J., Short, English, Morgan, G. J., Hale, G., & Hillmen (1999) · British Journal of Haematology · doi:10.1046/j.1365-2141.1999.01676.x · Cited by 67
Infections and serum IgG levels in patients with chronic lymphocytic leukemia
Itala, M., Helenius, H., Nikoskelainen, J., & Remes, K. (1992) · European Journal of Haematology · doi:10.1111/j.1600-0609.1992.tb01805.x · Cited by 67
Molica, S., Levato, D., & Levato, L. (1993) · PubMed · Cited by 44
Cortelezzi, A., Pasquini, M. C., Sarina, B., Bertani, G., Grifoni, F. I., Colombi, M., & Deliliers, G. L. (2005) · PubMed · Cited by 28
Advances in the use of monoclonal antibodies in the therapy of chronic lymphocytic leukemia
Lundin, J., & Österborg, A. (2004) · Seminars in Hematology · doi:10.1053/j.seminhematol.2004.05.005 · Cited by 19
Cited by
Requirement of Interleukin‐17A for Systemic Anti– Candida albicans Host Defense in Mice
Huang, W., Na, L., Fidel, P. L., & Schwarzenberger, P. (2004) · The Journal of Infectious Diseases · doi:10.1086/422329 · Cited by 859
Poirot, L., Philip, B., Schiffer-Mannioui, C., Le Clerre, D., Chion-Sotinel, I., Derniame, S., Potrel, P., Bas, C., Lemaire, L., Galetto, R., et al. (2015) · Cancer Research · doi:10.1158/0008-5472.can-14-3321 · Cited by 605
Where does a Staphylococcus aureus vaccine stand?
Fowler, V. G., & Proctor, R. A. (2014) · Clinical Microbiology and Infection · doi:10.1111/1469-0691.12570 · Cited by 241
“aureus infections No Morrison [86]”
BackgroundCoutre, S. E., Byrd, J. C., Hillmen, P., Barrientos, J. C., Barr, P. M., Devereux, S., Robak, T., Kipps, T. J., Schuh, A., Moreno, C., et al. (2019) · Blood Advances · doi:10.1182/bloodadvances.2018028761 · Cited by 134
Stimulated Innate Resistance of Lung Epithelium Protects Mice Broadly against Bacteria and Fungi
Evans, S. E., Scott, B. L., Clement, C. G., Larson, D. T., Kontoyiannis, D., Lewis, R. E., LaSala, P. R., Pawlik, J., Peterson, J. W., Chopra, A. K., et al. (2010) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2008-0260oc · Cited by 129
Metadata
- Authors
- WADHWA, P., & MORRISON, V
- Venue
- Seminars in Oncology
- Publisher
- Elsevier BV
- Published
- 2006-04
- Volume
- 33
- Issue
- 2
- Pages
- 240-249
- ISSN
- 0093-7754 (ISSN-L)
- OpenAlex
- W1969252807
- Cited by
- 276
- References
- 39
- FWCI
- 6.56
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.